Fluonic to Present at OneMedForum in San Francisco

Share Article

Emerging-company finance conference selects Colorado digital health and information company.

News Image

OneMedForum has selected Fluonic, Inc., to present at its eighth annual emerging-company finance conference Jan. 12-13 in San Francisco.

Fluonic, Inc., is a digital health and information company that provides monitoring of infusion drug delivery with patented flow measurement and control technology. The company’s products solve the problem that the $10 billion drug infusion market cannot accurately measure the flow of medication from infusion pumps to patients, particularly very low flows.

OneMedForum connects emerging healthcare, life sciences and medical technology companies, capital, expertise, and technology. This year’s event will include more than 100 innovative, high-quality, promising growth companies and 1,300 investors. According to the organization, by connecting companies and investors, the forum helps advance the firms shaping the future of health and medicine.

At the conference, Fluonic will discuss its technology and flagship product, the SURE+ fully disposable infusion system. The system, which measures the actual flow rate to the patient in real time, allows remote monitoring of the infusion procedure, and provides auto adjustments and alarms.

Presenting a solution for a faulty life-dependent medical system
“OneMedForum will give Fluonic the opportunity to present, to the right audience, its cost-effective, scalable solution for a problem that has afflicted the health care industry for more than 30 years,” says Jim Kasic, CEO of Fluonic. While more than 90 percent of hospitalized patients receive some type of intravenous drug therapy, and hundreds of thousands more receive intravenous drug therapy at home or on an out-patient basis, the pumps that deliver the medication operate blindfolded, unable to verify what they actually deliver to the patient, he explains. The industry is plagued with recalls of hundreds of thousands of faulty pumps.

Fluonic’s sensor, Kasic states, is accurate over the entire flow range, delivers information on the medication flow to designated recipients, wirelessly, and senses very low flows very precisely. As a result, health care providers can better control infusion drug delivery, and patients can receive more types of drugs at home, effectively reducing hospital stays and visits, and outpatient clinic visits. “Fluonic is creating the opportunity for a new standard of care, taking the questions and guesswork out of infusion drug therapy.”

Fluonic, Inc. (http://www.fluonic.com)
Based in Boulder, Colo., Fluonic, Inc., is a digital health and information company that provides monitoring of infusion drug delivery with patented flow measurement and control technology. The company’s products, including the flagship VariFlow sensor, solve the problem that the $10 billion drug infusion market cannot accurately measure the flow of medication from infusion pumps to patients, particularly very low flows. Initial applications include elastomeric infusion pumps and critical care equipment.
(end)

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Aimee Bennett
Fluonic Inc.
+1 303-843-9840
Email >

Jim Kasic